Your skin is changing.
There is a reason—
and a solution.

RevelleCare is designed for women in perimenopause or menopause who are experiencing skin changes — including dryness, thinning, loss of firmness, fine lines, or uneven texture — that they believe may be related to declining estrogen. You must be 18 or older and located in Ontario or British Columbia to access our services at launch.

No referral is needed. RevelleCare Nurse Practitioners are independently licensed to assess and prescribe. You can access your consultation directly through our platform without seeing your GP first — though we always recommend keeping your primary care provider informed of any treatments you are receiving.

Nurse Practitioners (NPs) are registered nurses with advanced graduate-level education who hold independent prescribing authority in Canada. They are licensed to assess, diagnose, and prescribe medications — including compounded topical formulations — without physician oversight. All RevelleCare NPs are registered with their provincial college (CNO in Ontario, BCCNM in BC) and have experience in women's health and hormonal care.

Compounded skincare is prepared by a licensed compounding pharmacy specifically for an individual patient, against a valid prescription from their healthcare provider. Unlike mass-manufactured products, every RevelleCare prescription is made to order — your formulation, your name, your dosage. This allows your NP to prescribe active pharmaceutical ingredients (such as estradiol and estriol) that are not available in any over-the-counter or commercially manufactured topical product in Canada.

Topical estrogen applied to the skin delivers much lower systemic absorption than oral or transdermal hormone therapy. Clinical research on topical estrogen applied to facial skin shows it is well-tolerated, with a strong safety profile when used as directed. Your NP will review your full medical history — including any personal or family history of hormone-sensitive conditions — before determining whether a prescription is appropriate for you. As with any prescription, there are individual risks, which your NP will discuss with you during your consultation.

Not everyone is a candidate for prescription hormonal skincare, and that is okay. RevelleCare's Non-Hormonal Repair Cream is available without a prescription and provides a high-performance alternative using clinically active ingredients including Vitamin B3 (niacinamide), Vitamin C, Vitamin E, and peptides. Your NP will guide you toward the most appropriate option during your consultation.

Yes. Every RevelleCare consultation includes a live virtual appointment with your NP — by video or phone. This is a genuine clinical assessment, not an automated questionnaire review. Your NP will speak with you directly, ask follow-up questions, and discuss your treatment options before any prescription is issued. We believe the NP-patient relationship is at the heart of safe, personalized care.

After submitting your intake form, you will be contacted to schedule your virtual NP consultation. We aim to offer consultations within 5–7 business days of submission at launch. Once your prescription is issued, your compounded formulation will be prepared and shipped within 3–5 business days.

There is a one-time $50 CAD intake consultation fee, charged at the time of your initial NP appointment. Your prescription formulation is billed as a 3-month supply: $195 CAD for our hormonal Rx creams, or $115 CAD for the Non-Hormonal Repair Cream. Annual renewals include a $50 CAD NP renewal fee. There are no hidden subscription charges — you are billed per supply when you choose to renew.

Compounded prescription products are not covered by provincial health plans (OHIP, MSP). Coverage through private extended health benefits varies by plan. We recommend contacting your benefits provider with the drug name and DIN (Drug Identification Number) to confirm your coverage. RevelleCare will provide you with all relevant documentation to support an insurance claim.

RevelleCare will launch in Ontario and British Columbia in Fall 2026. We plan to expand across Canada in 2027. Join our waitlist to be notified when we launch in your province.

Approximately 90 days before your prescription expires, you will receive a reminder to complete a new intake form. A new NP assessment is required before any renewal prescription is issued. There is no automatic refill. Your renewal NP may be the same practitioner or a different member of our clinical team — we will always ensure consistency in your care record.

No. RevelleCare provides a faster, more accessible way to receive a clinical assessment and prescription for menopausal skin concerns — but our service does not replace your primary care provider or specialist. We strongly encourage you to keep your GP or dermatologist informed of any treatments you are receiving through RevelleCare. For emergencies, call 911 or go to your nearest emergency room. RevelleCare is not intended for urgent or emergency medical situations.

Yes. All personal health information collected by RevelleCare is handled in accordance with PIPEDA (the Personal Information Protection and Electronic Documents Act) and applicable provincial privacy legislation, including PHIPA in Ontario and PIPA in BC. Your health information is never sold or shared with third parties for marketing purposes. Our platform uses encrypted, secure communication for all clinical records and consultations.